Comparison Y-Mabs Therapeutics (YMAB) with Competitors
Y-Mabs Therapeutics (YMAB) industry is Biotechnology.
Profit Margin
YMAB-16.59%
Industry-0.77%
Upside-15.82%
Operating Margin
YMAB-28.70%
Industry-2055.25%
Upside+2026.55%
Debt-to-Equity
YMAB3.66%
Industry28.27%
Upside-87.05%
Free Cash Flow Yield
YMAB-4.59%
Industry-1.75%
Upside-2.84%
P/E
YMAB-17.34
Industry-20.52
Upside+318.14%
P/S
YMAB4.57
Industry10.01
Upside-54.36%
P/B
YMAB4.46
Industry5.15
Upside-13.35%